AIMC Journal:
Hematological oncology

Showing 1 to 2 of 2 articles

Cutting-Edge Technologies to Decode Tumor Microenvironment in Multiple Myeloma.

Hematological oncology
Multiple myeloma (MM) is recognized as a malignancy shaped by its complex tumor microenvironment (TME), which fuels disease progression and therapeutic resistance. Recent advances in single-cell omics, spatial transcriptomics, mass cytometry, and adv...